No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

Malignant peritoneal mesothelioma presenting as a splenic mass

Our plain-English summary of Malignant peritoneal mesothelioma presenting as a splenic mass, by M. Podberezin, M.J. Fitzpatrick, L.P. Hariri, et al (Pathology, Research and Practice, 2020).

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The study

In plain English

This article is a case report, published as a letter, about one patient with peritoneal mesothelioma (mesothelioma of the abdominal lining) that first appeared as an enlarged spleen. A 52-year-old woman, otherwise healthy, had worsening pain in her left flank and left shoulder. A CT scan showed a mass inside the spleen measuring 14.2 cm. A core needle biopsy showed a high-grade tumor. Its microscopic features and stains were consistent with biphasic malignant mesothelioma. Because mesothelioma was not suspected at first, the biopsy stains did not include certain carcinoma markers. Surgeons removed the spleen together with parts of the liver, stomach, diaphragm and omentum. The tumor measured 24 cm and had also reached the stomach wall, the diaphragm and the omentum. Genetic testing found no changes that could be targeted with drugs. Despite chemotherapy, the cancer spread to the liver and lung, and she died five months after surgery. The authors concluded that this was locally advanced peritoneal mesothelioma mainly involving the spleen, which mimicked localized splenic mesothelioma. The article did not report whether the patient had been exposed to asbestos.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

  • Design: Case report (letter to the editor) of a single patient
  • Who was studied: One 52-year-old otherwise healthy woman with worsening left flank and left shoulder pain. The authors were at hospitals in Massachusetts, United States; the date of the case is not given.
  • Exposure: Not reported: the article gives no asbestos or other exposure history for this patient.
  • Main results:
    • CT of the abdomen showed an enlarged spleen with a mass inside the spleen measuring 14.2 cm in greatest dimension.
    • Core biopsy of the spleen showed a high-grade malignant tumor. Tumor cells stained positive for calretinin, WT-1 and GATA-3, with markedly diminished BAP-1 expression.
    • MTAP staining did not show loss of expression. The authors stated that this did not affect the diagnosis because the tumor was clearly malignant.
    • The biopsy findings were consistent with biphasic malignant mesothelioma with pleomorphic features.
    • The spleen was removed in one block with the left lateral segment of the liver, the omentum, the left hemidiaphragm and the greater curvature of the stomach.
    • On gross examination the tumor measured 24 cm. It involved the gastric wall and the left hemidiaphragm, with multiple tumor deposits in the omentum.
    • Next-generation sequencing found no targetable alterations. Variants in RNF43, TP53 and NF2 were detected.
    • Despite chemotherapy, the patient developed widespread metastases to the liver and lung and died five months after surgery.
    • Despite the enlarged spleen, the patient had a high platelet count (thrombocytosis) rather than a low one. Its cause was not clear; molecular studies ruled out a chronic myeloproliferative neoplasm.
  • The authors' conclusion: The authors concluded that the case represented locally advanced peritoneal mesothelioma with predominant involvement of the spleen, thus mimicking localized splenic mesothelioma.
  • Limitations the authors state:
    • Because the sample was a core biopsy and mesothelioma was not initially suspected, the stain panel did not include broad carcinoma markers such as Ber-Ep4 and/or MOC31.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma, Peritoneal mesothelioma.

Medical terms in this study, explained in our Lexicon: Peritoneal Mesothelioma.

Browse more research in Pathology, Research and Practice, or return to medical research.

Cited on this site

How to cite it

Cite the study

M. Podberezin, M.J. Fitzpatrick, L.P. Hariri, L. Sholl. Malignant peritoneal mesothelioma presenting as a splenic mass. Pathology, Research and Practice 2020;216(12):153273. doi:10.1016/j.prp.2020.153273. PMID: 33161309.

Cite our summary

“Malignant peritoneal mesothelioma presenting as a splenic mass.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/malignant-peritoneal-mesothelioma-presenting-as-a-splenic-mass.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.